SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

Share Price is delayed by 15 minutes
Get Live Data
0.944    0.00 (0.00%)
Bid:
0.944
Ask:
0.946
Spread: 0.002 (0.212%)
Market Cap: $1.06b
BPCR Live PriceLast checked at - London Stock Exchange

Intraday Biopharma Cred. Share Chart

Director/PDMR Shareholding

4 Nov 2025 15:29

RNS Number : 1680G
BioPharma Credit PLC
04 November 2025
Β 

4 November 2025

Β 

BIOPHARMA CREDIT PLC

Β 

Notification of Transactions by

Persons Discharging Managerial Responsibilities and

Persons Closely Associated with them

Β 

1.

Details of person discharging managerial responsibilities/person closely associated with them

a)

Name

Anita Hyman

2.

Reason for the notification

a)

Position / status

Person Closely Associated with Harry Hyman (Director of BioPharma Credit PLC)

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

BioPharma Credit PLC

b)

LEI

213800AV55PYXAS7SY24

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Β 

Identification Code

Ordinary Shares of $0.01 each

Β 

Β 

GB00BDGKMY29

b)

Nature of the transaction

Purchase of Shares (acquired as part of dividend reinvestment)

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Β£0.693518

62

d)

Aggregated information

- Aggregated volume

Β 

- Price

Β 

Β 

N/A

Β 

Β 

e)

Date of the transaction

03.11.2025

f)

Place of the transaction

London Stock Exchange (XLON)

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHBUBDBIDGDGUS
Date   Source Headline
9th Jun 20268:00 amRNSNEW INVESTMENT
3rd Jun 202611:40 amRNSNew Investment
1st Jun 20264:51 pmRNSDirector/PDMR Shareholding
1st Jun 20261:39 pmRNSTotal Voting Rights
26th May 20266:15 pmRNSTransaction in Own Shares
22nd May 20266:15 pmRNSTransaction in Own Shares
22nd May 20264:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st May 20266:15 pmRNSTransaction in Own Shares
20th May 20266:15 pmRNSTransaction in Own Shares
15th May 20266:15 pmRNSTransaction in Own Shares
6th May 20265:47 pmRNSTransaction in Own Shares
6th May 20267:00 amRNSSTATEMENT RE ALPHATEC PREPAYMENT
6th May 20267:00 amRNSNotice of AGM
5th May 20267:00 amRNSStatement re ARCHIMED
1st May 202612:09 pmRNSTotal Voting Rights
29th Apr 20266:15 pmRNSTransaction in Own Shares
29th Apr 20265:03 pmRNSHolding(s) in Company
27th Apr 20266:15 pmRNSTransaction in Own Shares
24th Apr 20264:00 pmRNSNet Asset Value(s) and Monthly Factsheet
22nd Apr 20264:10 pmRNSDividend Declaration
16th Apr 20265:59 pmRNSDirector/PDMR Shareholding
14th Apr 20265:44 pmRNSTransaction in Own Shares
13th Apr 20265:07 pmRNSTransaction in Own Shares
10th Apr 20265:36 pmRNSTransaction in Own Shares
10th Apr 20267:00 amRNSInvestor Presentation via Investor Meet Company
10th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20266:15 pmRNSTransaction in Own Shares
25th Mar 20266:23 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSAnnual Financial Report
20th Mar 20264:00 pmRNSNet Asset Value(s) and Monthly Factsheet
18th Mar 202611:26 amRNSUPDATE ON INVESTMENT PORTFOLIO
17th Mar 20267:00 amRNSNEW INVESTMENT OF US$125 MILLION
17th Mar 20267:00 amRNSNEW INVESTMENT OF US$125 MILLION
2nd Mar 20261:39 pmRNSUPDATE ON INVESTMENT
20th Feb 20264:00 pmRNSNet Asset Value(s) and Monthly Factsheet
10th Feb 20265:20 pmRNSDividend Declaration
3rd Feb 20267:00 amRNSNotice of Full Year Results
23rd Jan 20264:00 pmRNSNet Asset Value(s) and Monthly Factsheet
30th Dec 20251:32 pmRNSSTATEMENT RE COLLEGIUM PREPAYMENT
30th Dec 20251:32 pmRNSSTATEMENT RE COLLEGIUM PREPAYMENT
19th Dec 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Nov 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
4th Nov 20253:29 pmRNSDirector/PDMR Shareholding
24th Oct 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Oct 20257:00 amRNSUPDATES ON INVESTMENT PORTFOLIO
7th Oct 20257:00 amRNSNEW INVESTMENT OF US$30 MILLION
23rd Sep 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
22nd Sep 20257:00 amRNSHalf-year Report
18th Sep 20255:15 pmRNSDividend Declaration
3rd Sep 202512:21 pmRNSNEW INVESTMENT OF UP TO US$62.5 MILLION

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.